# Puma Biotechnology (PBYI) — Analyst Forecast

PBYI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pbyi/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 0 | 1 | 0 | 1 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 7, 2026 | TD Cowen | Maintained | Hold | $6.00 |
| Feb 28, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Dec 23, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Nov 20, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Aug 2, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Jul 26, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Jun 4, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Jun 3, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| May 20, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| May 3, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Feb 13, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Sep 20, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Aug 4, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| May 5, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### Is PBYI a buy, sell, or hold?

Analysts covering Puma Biotechnology currently average a Hold rating: 0 buy, 1 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on PBYI?

On Aug 7, 2026, TD Cowen maintained Puma Biotechnology at Hold with a price target of $6.00.

## Similar Stocks

- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock
- [CTMX](https://www.lighthorse.io/tickers/ctmx) — CytomX Therapeutics, Inc. - Common Stock
- [TRDA](https://www.lighthorse.io/tickers/trda) — Entrada Therapeutics, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).